Quick Search

 

 


 

 

Home > Result Summaries: Compounds > fosamprenavir > Result Summary for LEX106430

Result Summary for LEX106430

Result Summary
Protocol ID: LEX106430
Clinical Study ID: LEX106430
Official Title: See detailed description.
Phase: phase 3
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: fosamprenavir
Trade/Product Name: Telzir,Telzer,Lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Cohen C, DeJesus E, LaMarca A, et al. Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS trial. [HIV Clin Trials]. 2010;11(5):239-247.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.